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Biological bismuth
Synthesis
Metathesis: AX2 + 2 MS2COR         A(S2COR)2 + 2MX
Molecular bismuth compounds, a panacea 
for human disease? 
Biological bismuth
Preparation of {Bi(S2CNEt2)3}2
Two hours
Dimeric structure of {Bi(S2CNEt2)3}2
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Single-crystal X-ray crystallography
Preparation of {Bi(S2CNEt2)3}2
Green chemistry
gastric and duodenal ulcers:
De-Nol®             Pepto-Bismol®            Pylorid® 
(coll-Bi subcitrate)         (Bi subsalicylate)       (rantidine Bi citrate)
Bismuth and Medicine
262 or 524 mg/ml
…caused by stress, spicy foods and too much acid
Harms stomach lining
Stimulates immune response
Inflammation
Helicobacter pylori
http://www.pcsg.org.uk/html/dis_helicobacter.html
Copyright: Luke Marshall, www.hpylori.com.au
Harms stomach lining
Stimulates immune response
Inflammation
C & N News, October 10, 2005
http://www.pcsg.org.uk/html/dis_helicobacter.html
Copyright: Luke Marshall, www.hpylori.com.au
http://www.helico.com/
Helicobacter pylori
Helicobacter pylori :
Mechanism of action (?):
IPNET.LAB
The Interactive Pathology Laboratory
Bismuth subsalicylate
“Bi”
H+
Inactivates F1-ATPase
Binding to transferrin
and lactroferrin
Bismuth compounds: pro-drugs
H.p. causative agent for gastrointestinal cancers
WHO: class 1 carcinogen
Combine bismuth with ‘useful’ thiols
Bismuth compounds and cancer
Radiation therapy: inhibition of SOD
Anti-cancer effects:
reduces alkylation of DNA
combination therapy with cisplatin
Dithiocarbamates in biology
Significant contribution of: 
- a very effective chelator for metals 
Dithiocarbamates in biology
Cu: Wilson’s disease
Ru: anti-viral 
Sn: anti-microbial
Fe: anti-HIV
Pt, Pd, Sn & Au: anti-tumour potential
Metal dithiocarbamates in medicine
Hogath (2012)
Dimeric structure of {Bi(S2CNEt2)3}2
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MRC-5 Cells
normal                            treated
IGROV-1 MCF-7
cisplatin 169 699
DOX 60 10
MTX 7 18
ETO 580 2594
Bi(dedtc)3 < 3.2 4
TAX < 3.2 < 3.2
Cytotoxicity (ID50; ng/ml):
Ovarian & breast cancers, Kaposis’ sarcoma,
non-small-cell lung cancer
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Taxol (Paclitaxel®)
Natural product:
Pacific Yew
http://www.research.fsu.edu/researchr/fall2002/taxol.html
Six 100 year old trees / one patient
Ceased harvesting 1993
Taxol (Paclitaxel®)
Synthesis of Taxol (Paclitaxel®)
Multi-step organic synthesis
e.g. Holton synthesis: 40 steps – 2% yield
ChemEngNews 2003 Sept. 15th
Semi-synthetic route:  
taxane from English
yew tree – 35% yield
Preparation of {Bi(S2CNEt2)3}2
Alkyl chain             Me < Et > nPr > nBu
Branching              nPr > iPr & nBu > iBu
Ring                              n = 4 > n = 7
Aromatic                         inactive
Structure/activity relationship
Maximum Tolerated Dose – Balb/C mice
Four to five weeks
old
Male and Female
Controls –
20 day max.
via intraperitoneal
injection (i.p.)
Bi(S2CNEt2)3: 7 mg Bi / kg
Bi(S2CNBu2)3: > 50 mg Bi / kg
Oral administration
Bi(S2CNEt2)3: ~ 50 mg Bi / kg
Maximum Tolerated Dose – Balb/C mice
MTD – Balb/C mice
- Ovcar: Ovarian cancer
MTD = 7 mg Bi / kg
ID50 = < 3.2 ng Bi / kg
“Therapeutic index”
= > 2.2 x 106
Anti-tumour activity – Balb/C Nude mice
Anti-tumour activity – Balb/C Nude mice
Anti-tumour activity: OVCAR
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TWI: 54%
(day 26)
Anti-tumour activity: HT-29
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single-dose 
multi-dose
(1.4 mg/kg Bi/dose)
HepG2 cell death: apoptosis
Membrane permeability, DNA fragmentation,
caspase activities and PCR-array analysis indicate
extrinsic and intrinsic pathways



Cell cycle analysis, ROS, cytochrome C, cell invasion…
Average of 16 strains
Et N(CH2)4 n-Bu BSS
4                 8           256            16
MIC90 (µg/ml)
Killing Helicobacter pylori
with A/Prof Ho Bow & Sook Yin Lui
Severe Acute Respiratory Syndrome
http://www.smh.com.au http://www.germbusters.com.sg
EM: RNA virus
Avian Flu
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CONCENTRATION (µΜ)
 Py-Bi
 nBu-Bi
 Et-Bi
Sun Hongzhe et al.
Anti-bacterial activity
Bactericidal against Streptococcus pneumoniae
Exciting potential for medicine with important
advances waiting to be made!
Bismuth-Based Drugs
“Bi”
anti-viral
anti-cancer
anti-bacterial
anti-HP
?
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Structure of Hg(S2CNEt2)2
HgS
N
Steric effects and secondary bonding
“Hg(S2CNR2)2”
Sum of the van der Waals radii for Hg and S = 3.35 Å
3.75 Å
increasing size of R
Conclusion #1
Au…Au
Systematic analyses enables new design elements
for crystal engineering
Crystal engineering?
Synthetic chemists: make molecules (covalent bonding)
CE’s: design crystals (parts of crystals) by controlling
intermolecular interactions
Conclusion #1
Au…Au
Systematic analyses enables new design elements
for crystal engineering
Crystal engineering?
Synthetic chemists: make molecules (covalent bonding)
CE’s: design crystals (parts of crystals) by controlling
intermolecular interactions, e.g. hydrogen-bonding,
halogen-bonding, secondary bonding, pi-pi, C-H…O, C-H…pi,
“emerging” interactions, etc.
Zinc thiolates: tuning supramolecular 
aggregation
Molecular paving with zinc xanthates
Tailoring luminescence
Structural diversity in Zn(S2COR)2
Examine structures for which R = Et, nPr & iPr
S
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CrystEngComm , 2002, 4, 596
isolated
tetramer
R = iPr
R = nPr
chain
layer
R = Et
Structural diversity in M(S2COR)2
Examine structures for which R = Et, nPr & iPr
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Ni(S2COR)2 for R = Et, nPr & iPr
R = iPr
R = nPr
R = Et
Te(S2COR)2 for R = Et, nPr & iPr
R = iPr
R = nPr
R = Et
Ab initio molecular orbital calculations 
on _S2COR
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Molecular paving with Zn(S2COR)2
≡
‘Molecular 
Paving stone’
Molecular paving with Zn(S2COR)2
R =
i-Pr
3-D exclusion zone
Molecular paving with Zn(S2COR)2
R =
n-Pr
2-D exclusion zone
Molecular paving with Zn(S2COR)2
R =
Et
Metal-organic frameworks & 
coordination polymers
Applications: gas storage/sensing; catalysis; 
luminescence; energy storage;
crystal sponge…
Coordination polymers of zinc-triad 
elements
Solid-state polymers cf. solution
A(S2COR)2 + bridging ligands
Zinc(1,1-dithiolate)2 + bpe
Zinc(xanthate)2 + bpe
R = Et
Zinc(xanthate)2 + bpe
R = Cy
Implications for solid-state luminescence
J.-G. Kang
Zinc(dithiophosphate)2 + bpe
R = Cy
R = iPr
Zinc(dithiocarbamate)2 + bpe
R = Me
Zinc(dithiocarbamate)2 + bpe
R = Me
R = Et
R = iPr
Zinc(dithiocarbamate)2 + bpe
Crystallisation with an excess bpe leads to a lattice adduct
R = Et
Explanation: electronic effects
Effective chelator for metals and reduces Lewis acidity
Cadmium(dithiocarbamate)2 + bpe # 1
R = Et
Increase the size of the metal centre
Conclusion #2
Au…Au
One can control supramolecular aggregation in
metal 1,1-dithiolates by:
electronic effects
size of the central element

Fortuna Eruditis Favet ("Fortune favours the prepared mind")
Sunway University
7th Asian Conference on Coordination Chemistry
22-26 July 2019 / Kuala Lumpur
You are welcome to visit the conference’s website at www.accc7.org.my for 
updates on ACCC7 or you can email us at accc7@ikm.org.my for further details.
